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The world has been assaulted by COVID-19. Unpredictable
changes in all sectors of economies and societies will manifest
themselves over the coming months and years. The most robust
health systems have become overwhelmed and pre-occupied in
response to the virus. The impact of COVID-19 will evolve from an
acute medical emergency response to a chronic ‘maintenance’
phase, with health services adapting to life with the virus as an-
other infectious agent. However, economic and societal costs will
vastly outweigh initial medical costs, given the widely predicted
global depression—trivial compared with the cost of prepared-
ness that should have been undertaken. The most vulnerable
in society will be driven into deeper poverty. The consequential
mental health morbidity and suicidal ideations will place an in-
creased burden on already overstretched services, against the
background of mental illness being the world’s leading cause of
morbidity.1 This is likely to be exacerbated by increased violence
and social stress on already depressed economieswith high levels
of unemployment. There may be hope for a vaccine, but its effi-
cacy, duration of immunity and the complexities of distribution
in low- and middle-income countries (LMICs) will be major chal-
lenges. The longer-term consequences of the pandemic for Africa
will be profound, given health system fragilities.2 In this editorial,
we discuss the potential impact of COVID-19 on neglected tropi-
cal disease (NTD) programmes as health services seek to function
in the newly changed COVID-19 environment.3
A view of the African context
The current recommended strategies to reduce transmission (iso-
lation, lockdown and social distancing) will be difficult to apply
and practice inmany African settings. In addition, with the preva-
lence of human immunodeficiency virus (HIV) and tuberculosis
(TB) in sub-Saharan Africa (HIV as an infection with a capac-
ity to immunosuppress and TB as a predominantly respiratory
condition) there will be serious implications for those carrying ei-
ther and often both conditions.4 In addition to TB, there are sev-
eral other significant causes of respiratory insufficiency in Africa.5
Many NTD infections also have the capacity to immunosup-
press in COVID-19 patients, and thus NTDs themselves represent
‘underlying health issues’. The limited surgical provision will be
overwhelmed by hospitalised patients occupying bed space, thus
patients in need of specialist care in rural settings will be un-
able to access medical care. There is also limited availability of
personal protective equipment (PPE). Immunization programmes
will likely be disrupted and the longer-term results of this are un-
predictable in younger children (measles potentially resurgent).
Medical and health staff will be at higher risk, thus depleting al-
ready limited human resources. Self-isolation in order to reduce
transmission will be difficult in many African settings. Although
behaviour change is notoriously difficult to message and imple-
ment, rapidly disseminated and socially acceptable messaging
needs to be developed as a matter of urgency. An antibody test
will be an essential tool to determine the true exposure of indi-
viduals and populations. The antibody test, when available, given
the huge global demand, may be less accessible to LMICs due to
affordability.
The consequences of sexual activity in the COVID-19 era
seems a taboo subject. There is a high risk of transmission from
any intimacy. Within the post-puberty population, multiple part-
ners is a high transmission risk behaviour. Until the prevalence of
asymptomatic carriers is known or if sexual activity is taking place
during an incubation period when the individual is infective, the
risks of sexual encounters cannot be factored into the transmis-
sion models.
A potential impact for NTD pharmaceutical donors might be
their ability to maintain drug manufacturing at current levels
given the complexity of the supply chain of active ingredients.
There is the potential for disruption of the supply chain because
of the closing of airports and increased costs of freight.
© The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License
(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,
provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
1
D
ow
nloaded from
 https://academ
ic.oup.com
/inthealth/article-abstract/doi/10.1093/inthealth/ihaa040/5877805 by guest on 30 July 2020
D. H. Molyneux et al.
The longer-term implications for NTD elimination and control
will be unclear for some time, but it is appropriate to envisage
and plan for various scenarios. Many NTD stakeholders will be im-
pacted by COVID-19 in their operational activities. Research or-
ganizations and institutions are temporarily closed and unable
to undertake funded laboratory-based work and field studies.
Drug distribution has been suspended and travel stopped or ex-
tremely limited, thus impacting the availability of technical sup-
port and the ability to monitor programmes. Health resources
may be overwhelmed by demand. In Sahelian countries politi-
cal instability driven by jihadist movements can be predicted to
increase food insecurity by reduced farming as a result of jihadist
control of rural areas, factors which together with COVID-19 will
create food price inflation for urban and rural populations. The
current locust swarms in eastern Africa pose a further challenge
to NTD-endemic countries, with a loss of crops over a significant
area and the resulting food insecurity, to which (given the scale)
the World Food Programme will be challenged to respond.
It can be predicted that the pandemic will have a differen-
tial impact on African countries given their different geographies,
economic situations, population sizes and health systems. Some
countries haveNTDprogrammeswith a history of success to date,
while others can be categorised into those most at risk of COVID-
19 impact, especially given their relatively weak health systems,
limited capacity, difficulties of access and insecurity and fragile
governance.2,3 A depleted health system caused by COVID-19
impact on health staff will have potentially catastrophic conse-
quences for the short to medium term on all health activities,
while economic stagnation and recession will impact the poorest
as economies fall into recession. Climatic factors may be relevant
if COVID-19 is less likely to survive the high temperatures prevail-
ing in the tropics. However, some 40% of the total population live
in urban or peri-urban settings where social distancing and hy-
giene are physically impossible or extremely difficult even if the
population is prepared to adhere to the message. In urban areas
there is a significant proportion of individuals with chronic heart
diseases and diabetes as a result of the demographic changes in
recent years, with a higher level of vulnerability in older adults.6
However, the overall clinical impact may be less, given the high
proportion of the population that is younger than inWestern soci-
eties. In Africa, themedian age is between 15 and 20 y, in Europe
themedian age is 40 y, but in Africa even younger age groups are
likely to have a higher frequency of underlying health conditions.7
This is not the case in Europe or the USA, where older age groups
have chronic conditions and benefit from access to healthcare
and the ability to access high-quality specialist services.
Traditionally, LMICs have appealed in emergencies for United
Nations (UN), International Monetary Fund (IMF), bilateral or
charitable sector support, but it is likely that because of the
global nature of the pandemic these traditional donor sources
will not have the liquidity to support LMICs given their own needs
to provide social and economic support to their populations. The
economic impact for countries heavily dependent on traditional
financing through loans will be serious given their inability to
repay interest, resulting in defaulting on debt as their economies
fall into recession. The IMF and World Bank have committed to
offering support, but the conditions associated with this com-
mitment are unclear.8 Figure 1 provides a summary of some of
the potential projected impacts of COVID-19 on NTD-endemic
countries in terms of social and economic factors
High-population countries
Countries with high-density populations in large coastal cities
such as Lagos, Accra, Dakar and Abijan, with relatively strong
health systems, have some comparative advantage in terms
of capacity. However, traditionally there is a huge amount of
in-country travel in crowded vehicles, suggesting the virus will
spread rapidly despite some current restrictions. The crowded
road transport systems in many African countries are not com-
patible with social distancing.
Clearly, even in the more developed LMICs there will be a
significant impact on the local economies. With falling oil prices,
several countries will lose significant revenue from which it may
take years to recover (if the projected global recession occurs
post-COVID-19 and oil prices remain at low levels). There could
be potential impact on coffee and cocoa production and other
agricultural export crops, with resultant declines in foreign ex-
change earnings through disruption of harvesting, freight and
reduced global demand.
Post-conflict and Ebola countries
The countries that shared the impact of Ebola could be best
equipped to deal with an emergency response, given their recent
experience in pandemic response (e.g. contact tracing and iso-
lation) and having human resources with skills for dealing with
the ‘critical care’ of Ebola cases as well as being able to un-
derstand the personal protection equipment (PPE) measures re-
quired.Whether the needed resources and latent capacity can be
mobilised will be an important part of the response.9
Sahelian and landlocked countries
Landlocked Sahelian countries will be under significant stress of
insecurity, as jihadist groups are presenting governmentswith se-
rious problems in Burkina Faso, Mali and northeast Nigeria. Po-
litical stability is fragile and COVID-19 could be a tipping point
for these countries, impeding future growth. The impact of cli-
mate change and drought will be more pervasive in the Sahel
and this will exacerbate existing conflicts between pastoralists
and sedentary farming communities. Imports will be curtailed,
given coastal ports are located hundreds of kilometres from ma-
jor inland centres and, in particular, problems with oil supplies.
Refugees and internally displaced camps in the Sahel have the
least chance of COVID-19 mitigation given the crowded nature
of such environments, pressure on medical services and limited
food supplies and sanitation/wash facilities. The supply chain
from the coast will be disrupted and food security compromised,
with potential price rises further impoverishing the poor.
Informal communities and COVID-19
high-risk groups for infection and
dissemination: mining, nomadic communities
and pastoralists
Many parts of West Africa have established informal mining
communities, particularly gold mining. These camps have lim-
ited social and organisational structures and attract workers
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Figure 1. Broader impacts of COVID-19 in NTD-endemic countries.
from several countries who exploit the resources and then
move to other sites that are more productive (often dependent
on the gold price). These populations are highly mobile, have
better cash availability, have reliable communication systems
(cell/smartphones with quality coverage by networks even in
the most remote areas) and circulate throughout the region
regardless of frontiers. Such camps have limited access to
healthcare and hygiene and access to safe water supplies is
limited. These populations, although small, should be recog-
nised as a potential hazard for COVID-19 transmission and its
dissemination. Efforts to identify the locations of such activities
present a challenge to the formal health sector to communicate
the necessary preventive messages to comply with transmission
mitigation behaviours. Similarly this will apply to internally
displaced persons camps.
Throughout the Sahel, nomadic (usually pastoralist) popula-
tions are usually outside the traditional health and education sec-
tors and the services they provide. These populations pose a chal-
lenge of access, communication and provision of services.10
Many traditional migration patterns (cross borders) exist in
West Africa, often associatedwith seasonal labour for agricultural
activities and distant from resident communities. Community-
directed distributors (CDDs), who have been the backbone of the
distribution of NTD medicines in rural communities, recognize
these migratory patterns, having timed mass drug administra-
tion (MDA) to be undertaken to ensure maximum coverage, and
thus they can assist in providing the necessary information to the
formal health sector.
The ‘double whammies’
COVID-19 is testing all countries. However, some LMICs will find it
difficult to copewithwhat can be identified as the ‘doublewham-
mies’ the pandemic imposes. Already there are areas of conflict
and insecurity. Ebola remains a problem in eastern Democratic
Republic of the Congo, locust swarms are ravaging the Horn of
Africa in east African countries and refugee camps and internally
displaced people camps are present in several countries, where
even before COVID-19 emerged, the challenge of providing ade-
quate resources to provide for the populationswas present. Donor
and UN funding will be less easy to access given the global de-
mand for the funds to cope with the pandemic.
Potential impact on NTD programmes
The World Health Organization (WHO) produced guideline rec-
ommendations regarding NTD activities as the pandemic de-
veloped11 and countries will want to work within these guide-
lines, but also ensure, when appropriate, that there is a timely
resumption of NTD activities, including MDA. It is essential that
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programmes work through a robust risk mitigation strategy as
part of the process to return to treatments at scale. The risk miti-
gation process may well bring a change to the usual approaches
for MDA, which could lead to increased time being spent on the
programme by the CDDs and programme staff.
However, NTD programmes have relied on volunteer CDDs
and many thousands have been trained since the early 1990s.12
While there has been some attrition in CDDs, those with past
experience can be recruited back to assist in messaging and
community response to COVID-19. There is a significant cadre
of human resources at the periphery of the health system who
are embedded in and have the confidence of their local com-
munities. Their rapid mobilisation, if provided with COVID-19
information, could be an effective mitigating factor in reducing
the spread and transmission of the virus. Mobilisation of CDDs will
be essential if formal health staff are not available due to COVID-
19, while the smartphone and cell phone network using the short
message service have a key role to play as demonstrated by the
Global Trachoma Mapping Project (GTMP) and for recording the
locations of patients who have symptoms of lymphatic filariasis.
The key question is ‘Can the information andmaterials be cre-
ated and socially and culturally nuanced for those who need it
and then be rapidly disseminated?’ There will be a need to as-
sess the reach of communications systems and cell phone usage
while engaging rural FM radio and state radio broadcasts.
Due to the risks, surgery for trichiasis and hydrocele has been
suspended. A future concern is that trichiasis, cataract surgeries
and anaesthesia for hydrocele involving close contact with pa-
tients could be compromised in the medium term whilst there
will be extra costs for future surgery due to the need for Personal
Protective Equipment (PPE). This is because the extent of asymp-
tomatic carriage in the population is, as yet, unknown. When an
approved antibody detection test for COVID-19 becomes avail-
able, NTD stakeholders should define its deployment in relation
to risk mitigation in surgical facilities/eye camps for protection of
patients, surgeons and nursing staff.
NTD programmes are seeking to address the inclusion of peo-
ple with disabilities in development programmes. There is an in-
creasing recognition that COVID-19 will have specific impacts on
this population group, both through lack of access, or even denial
of access, to health services and also through social distancing,
undermining the critical support services they require to secure
even their basic needs and to benefit equally from COVID-19-
focused programmes. The UN Secretary General developed a pol-
icy brief on the dimensions of disability and COVID-19 entitled ‘A
disability-inclusive response to COVID-19’.13 Within the context of
‘leave no one behind’ and ‘equity’, particularly access to services,
this document emphasises the obligations of the NTD commu-
nity and its aspirations to serve those with the diverse disabilities
associated with NTDs, including their mental health.14
Hand, face and limb hygiene is a significant component of
several NTD intervention strategies.15 COVID-19 provides an op-
portunity to maximise the impact of this strategy for NTD trans-
mission control and morbidity management. However, the costs
and availability of soap is a potential impediment to scaling up
this critical activity. Expansion of the Water, Sanitation and Hy-
giene (WASH) program messaging provides an opportunity for
the WASH, behaviour change and communication approaches
(with an added impact on diarrhoeal diseases) tomitigate COVID-
19 transmission as well as impacting NTDs. However, in many
settings the absence of safe water provision and the cost and
availability of soap are constraints to this approach.
NTD programmes have been innovative in developing
community-directed treatment16 and school-based distribu-
tion strategies17 to ensure the necessary treatment coverage.
The introduction of the dose pole to avoid weighing patients, a
means of providing the correct dosages of drugs and identifying
those children not eligible for treatment, has been an innova-
tive and emblematic symbol of MDA programmes throughout
Africa.18 Using dose poles, which are approximately 2m in length,
to inform behaviours compatible with social distancing would
be an effective way to provide health education. The thinking
around how dose poles could be adapted for providing drugs,
accepting that social distancing will need to be maintained into
the foreseeable future, should be investigated. Communities
should be engaged in considering the most appropriate ways to
deliver drugs in the new scenario. This should also include the
need for safely providing water for patients to swallow drugs and
ensuring drugs are swallowed if house to housedistribution is the
safest method of MDA. These challenges need to be addressed
and considered immediately.
Drug expiry
Donor-funded NTD programmes can play of role in supporting
country programmes with accurate and up-to-date drug inven-
tories as requested by the WHO and European Society for Clin-
ical Nutrition and Metabolism. The wider issues of drug supply,
scaled back manufacturing and limited delivery options are po-
tential constraints in the coming months. The engagement with
the Supply Chain Forum will be an opportunity to be updated
on global impacts. The potential problem of expiry of MDA drug
stocks with MDA programme suspensions should be evaluated.
The numbers of drugs that might expire given that MDA will be
delayed for different periods of time (6 months, 1 y etc.) should
be communicated by countries to the WHO and the pharmaceu-
tical donors.
National coordination activities
The functioning of national-level coordination mechanisms (e.g.
the national COVID-19 task forces and UN country coordinating
teams) will play an essential role in monitoring the response to
COVID-19. NTD programmemanagers are integral to the national
response, as they can offer advice and perspectives. Emergency
response regarding behaviour change and communication (BCC)
messages, in particular, relating to WASH, communications with
communities and mobilisation of the CDD resource, should be at
the forefront of the national strategy if an effective COVID-19 re-
sponse is to be achieved at scale. The NTD community commu-
nication experiences and systems can lead country responses in
social distancing, surveillance, communication and information.
These are mitigation activities that can be activated almost im-
mediately.2
NTD elimination targets
Endorsement by the Executive Board of the WHO of the
NTD Road Map 2020–2030 was expected to be confirmed by
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Figure 2. Summary of possible impacts on NTD programmes.
the World Health Assembly (WHA) in May.19 However, a vir-
tual WHA was held with a COVID-19-only agenda. Clearly it
is difficult to anticipate the potential COVID-19 impact on
the aspirations of the new road map, but the WHO has
planned regular appraisals of progress and recalibration; how-
ever, with the WHO guidelines and MDA activities suspended,
this will create a window when transmission of infections
could increase. This might be mitigated by increased im-
pact of social messaging regarding WASH and BCC messag-
ing if implemented during the early phase of the pandemic,
thereby impacting transmission, in particular for trachoma,
lymphatic filariasis and soil-transmitted helminths. The nec-
essary maintenance of surveillance for guinea worm (GW)
in those countries previously certified as free of transmis-
sion as well as activities in those countries that remain en-
demic (Angola, Chad, Ethiopia, Mali and South Sudan) might
be impaired. However, the village health workers involved in
GW active surveillance can be a valuable resource in expand-
ing messages related to COVID-19.20 Ironically, both COVID-
19 and guinea worm require case containment and contact
tracing.21
Figure 2 shows the potential negative impacts on NTD pro-
grammes in endemic countries and also demonstrates how
adapting (flexing) can facilitate the overall impact of NTD activi-
ties on mitigating COVID-19.
Conclusion
This article seeks to identify the broader geopolitical and societal
situation that the COVID-19 pandemic presents (Figure 1). The sit-
uation is evolving rapidly and NTD activities will need to adapt to
a ‘new normal’. However, the poorest countries andmost vulner-
able communities and individuals will be those least able to cope
andmitigate transmission risk. NTD partners have an opportunity
to react and provide support within the framework of adapting
novel approaches in ways that assist the response to COVID-19
in practical ways. This emphasises the value of interventions be-
yond MDA and the existence of a vital volunteer resource. The
CDDs providing onchocerciasis treatments reached communities
‘beyond the end of the road’ with health interventions such as vi-
tamin A distribution, bed nets and family planning16—they could
now embrace the COVID-19 healthmessage. We suggest the fol-
lowing (see Figure 2):
 Immediately utilise existing NTDmobile cell/smartphone tech-
nology to act as a COVID-19 surveillance system for national
authorities already deployed by NTD programmes.
 Upscale the existing and latent CDD volunteer network as an
immediately available resource.
 Ramp up the WASH messaging as a part of the coun-
try response to send COVID-19 messages regarding hand
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washing/hygiene; explore soap donations/subsidies via local
actors and producers.
 Assess the risks of surgery, both in the short and longer term,
to staff in close contact with patients and ensure downstream
availability of necessary PPE; assess the feasibility of antibody
testing to ensure surgery can take place as soon as it is safe to
do so.
 Reassess elimination targets within national plans for NTDs if
MDA is delayed.
 Explore the latent capacity for critical care support in post-
Ebola countries and PPE availability.
 Seek to utilise the potential of antibody testing for staff and
wider groups to reassess the post-acute phase spread, thus
evaluating the risk to future activities.
 Countries should examine new approaches to MDA, such as
house-to-house distribution, and ensure stocks of medicines
are available in clinics for children <5 y of age and for school
distribution when schools reopen.
COVID-19 has preoccupied the global community recently and
will continue to do so. It should not impair the need for other es-
sential health activities. This applies to NTDs in particular, where
the commonality of interventions, systems and human resources
(both formal and informal) will have a major impact both on the
virus and diseases throughmitigating impact and reducing trans-
mission.
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